Nancy U. Lin, MD, is a medical oncologist specializing in the care of patients with all stages of breast cancer and a Scientific Advisor for ArteraAI. Her research focuses upon developing novel therapies for patients with metastatic breast cancer and in understanding mechanisms of therapeutic resistance, with a particular focus on the challenge of treating breast cancer brain metastases. She has led multiple clinical trials on novel systemic approaches for metastatic breast cancer. Her work has resulted in new treatment options for patients with metastatic breast cancer, including patients with breast cancer brain metastases.

Dr. Lin received her MD from Harvard Medical School. She completed her residency in internal medicine at Brigham and Women’s Hospital and went on to complete fellowships in medical oncology and hematology at Dana-Farber Cancer Institute. In 2005, she joined the faculty at Dana-Farber, where she currently serves as the Associate Chief and Director of the Metastatic Breast Cancer Program in the Division of Breast Oncology.